✦ LIBER ✦

607 High incidence of de novo diabetes mellitus type 1 during or after treatment with pegylated interferon in patients with chronic hepatitis C virus infection

✍ Scribed by T.C.M.A. Schreuder; H.G. Gelderblom; C.J. Weegink; H.W Reesink; J.B.L. Hoekstra; P.L.M. Jansen

Book ID: 117374883
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 110 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80607-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High incidence of type 1 diabetes mellit

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

✍ Tim C. M. A. Schreuder; Huub C. Gelderblom; Christine J. Weegink; Dörte Hamann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Phase 1b study of pegylated interferon l

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

✍ Andrew J. Muir; Mitchell L. Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Interferon lambda 1 (IFN-k1) is a type III IFN that produces intracellular responses similar to those of IFN-a but in fewer cell types because of differences in the receptor distribution pattern, and this could potentially result in an improved safety profile. This was an open-label three-part study

Simeprevir with pegylated interferon alf

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

✍ Manns, Michael; Marcellin, Patrick; Poordad, Fred; de Araujo, Evaldo Stanislau A 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 287 KB